
### [MONDO:0019523](http://purl.obolibrary.org/obo/MONDO_0019523)
**Label:** Walker-Warburg syndrome

**Subclasses:** [MONDO:0014101](http://purl.obolibrary.org/obo/MONDO_0014101) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12), [MONDO:0013904](http://purl.obolibrary.org/obo/MONDO_0013904) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8), [MONDO:0014120](http://purl.obolibrary.org/obo/MONDO_0014120) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13), [MONDO:0014022](http://purl.obolibrary.org/obo/MONDO_0014022) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10), [MONDO:0014683](http://purl.obolibrary.org/obo/MONDO_0014683) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9), [MONDO:0013835](http://purl.obolibrary.org/obo/MONDO_0013835) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 7), [MONDO:0018280](http://purl.obolibrary.org/obo/MONDO_0018280) (muscle-eye-brain disease with bilateral multicystic leucodystrophy), 

**Corr. equiv. classes:** [OMIM:616538](http://purl.obolibrary.org/obo/OMIM_616538), [OMIM:614830](http://purl.obolibrary.org/obo/OMIM_614830), [OMIM:614643](http://purl.obolibrary.org/obo/OMIM_614643), [OMIM:615249](http://purl.obolibrary.org/obo/OMIM_615249), [OMIM:615041](http://purl.obolibrary.org/obo/OMIM_615041), [OMIM:615287](http://purl.obolibrary.org/obo/OMIM_615287), [Orphanet:370997](http://www.orpha.net/ORDO/Orphanet_370997), 

**Class expressions from DL-Learner:**

- [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 66.72%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 66.72%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 66.72%
- [HP:0001290](http://purl.obolibrary.org/obo/HP_0001290) (Generalized hypotonia) and [HP:0002119](http://purl.obolibrary.org/obo/HP_0002119) (Ventriculomegaly) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 64.29%
- [HP:0001290](http://purl.obolibrary.org/obo/HP_0001290) (Generalized hypotonia) and [HP:0002119](http://purl.obolibrary.org/obo/HP_0002119) (Ventriculomegaly) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) and [HP:0007973](http://purl.obolibrary.org/obo/HP_0007973) (Retinal dysplasia) 64.29%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 60.19%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 60.19%
- [HP:0001274](http://purl.obolibrary.org/obo/HP_0001274) (Agenesis of corpus callosum) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 60.16%
- [HP:0001274](http://purl.obolibrary.org/obo/HP_0001274) (Agenesis of corpus callosum) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 60.16%
- [HP:0001274](http://purl.obolibrary.org/obo/HP_0001274) (Agenesis of corpus callosum) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 60.16%
- [HP:0001274](http://purl.obolibrary.org/obo/HP_0001274) (Agenesis of corpus callosum) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 60.16%
- [HP:0001274](http://purl.obolibrary.org/obo/HP_0001274) (Agenesis of corpus callosum) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 60.16%
- [HP:0001274](http://purl.obolibrary.org/obo/HP_0001274) (Agenesis of corpus callosum) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 60.16%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) and [HP:0001274](http://purl.obolibrary.org/obo/HP_0001274) (Agenesis of corpus callosum) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 60.16%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0001274](http://purl.obolibrary.org/obo/HP_0001274) (Agenesis of corpus callosum) and [HP:0007260](http://purl.obolibrary.org/obo/HP_0007260) (Type II lissencephaly) 60.16%


